Cargando…

Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial

Glycemic control and weight reduction are primary goals for the management of overweight and obese type 2 diabetes mellitus (T2DM). Effective management cannot be achieved without an appropriate diet. Our study aimed to evaluate the short- and long-term effects of oat intake and develop a reasonable...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xue, Cai, Xiaxia, Ma, Xiaotao, Jing, Lulu, Gu, Jiaojiao, Bao, Lei, Li, Jun, Xu, Meihong, Zhang, Zhaofeng, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037534/
https://www.ncbi.nlm.nih.gov/pubmed/27618090
http://dx.doi.org/10.3390/nu8090549
_version_ 1782455757310001152
author Li, Xue
Cai, Xiaxia
Ma, Xiaotao
Jing, Lulu
Gu, Jiaojiao
Bao, Lei
Li, Jun
Xu, Meihong
Zhang, Zhaofeng
Li, Yong
author_facet Li, Xue
Cai, Xiaxia
Ma, Xiaotao
Jing, Lulu
Gu, Jiaojiao
Bao, Lei
Li, Jun
Xu, Meihong
Zhang, Zhaofeng
Li, Yong
author_sort Li, Xue
collection PubMed
description Glycemic control and weight reduction are primary goals for the management of overweight and obese type 2 diabetes mellitus (T2DM). Effective management cannot be achieved without an appropriate diet. Our study aimed to evaluate the short- and long-term effects of oat intake and develop a reasonable dietary plan for overweight T2DM patients. A randomized control trial, registered under ClinicalTrials.gov (Identification code: NCT01495052), was carried out among adult T2DM patients. A subgroup of 298 overweight subjects was selected and received a 30-day centralized intervention and 1-year free-living follow-up. Participants were randomly allocated to one of the following four groups. The usual care group (n = 60) received no intervention; the healthy diet group (n = 79) received a low-fat and high-fiber diet (“healthy diet”); the 50 g-oats group (n = 80) and 100 g-oats group (n = 79) received the “healthy diet” with the same amount of cereals replaced by 50 g and 100 g oats respectively. Anthropometric, blood glycemic and lipid variables were measured. For the 30-day intervention, significant differences in the changes of FPG (fasting plasma glucose), PPG (postprandial plasma glucose), HbA1c (glycosylated hemoglobin), HOMA-IR (homeostasis model assessment of insulin resistance), TC (total cholesterol), TG (total triglycerides), and LDL-c (low-density lipoprotein cholesterol) were observed among the four groups. Compared to the healthy diet group, the 50 g-oats group had a bigger reduction in PPG (mean difference (MD): −1.04 mmol/L; 95% CI: −2.03, −0.05) and TC (MD: −0.24 mmol/L; 95% CI: −0.47, −0.01); the 100 g-oats group had a bigger reduction in PPG (MD: −1.48 mmol/L; 95% CI: −2.57, −0.39), HOMA-IR (MD: −1.77 mU·mol/L(2); 95% CI: −3.49, −0.05), TC (MD: −0.33 mmol/L; 95% CI: −0.56, −0.10) and LDL-c (MD: −0.22 mmol/L; 95% CI: −0.41, −0.03). In the 1-year follow-up, greater effects in reducing weight (MD: −0.89 kg; 95% CI: −1.56, −0.22), HbA1c (MD: −0.64%; 95% CI: −1.19, −0.09) and TG (MD: −0.70 mmol/L; 95% CI: −1.11, −0.29) were observed in the 100 g-oats group. In conclusion, short- and long-term oat intake had significant effects on controlling hyperglycemia, lowering blood lipid and reducing weight. Our study provided some supportive evidence for recommending oat as a good whole grain selection for overweight diabetics.
format Online
Article
Text
id pubmed-5037534
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-50375342016-10-15 Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial Li, Xue Cai, Xiaxia Ma, Xiaotao Jing, Lulu Gu, Jiaojiao Bao, Lei Li, Jun Xu, Meihong Zhang, Zhaofeng Li, Yong Nutrients Article Glycemic control and weight reduction are primary goals for the management of overweight and obese type 2 diabetes mellitus (T2DM). Effective management cannot be achieved without an appropriate diet. Our study aimed to evaluate the short- and long-term effects of oat intake and develop a reasonable dietary plan for overweight T2DM patients. A randomized control trial, registered under ClinicalTrials.gov (Identification code: NCT01495052), was carried out among adult T2DM patients. A subgroup of 298 overweight subjects was selected and received a 30-day centralized intervention and 1-year free-living follow-up. Participants were randomly allocated to one of the following four groups. The usual care group (n = 60) received no intervention; the healthy diet group (n = 79) received a low-fat and high-fiber diet (“healthy diet”); the 50 g-oats group (n = 80) and 100 g-oats group (n = 79) received the “healthy diet” with the same amount of cereals replaced by 50 g and 100 g oats respectively. Anthropometric, blood glycemic and lipid variables were measured. For the 30-day intervention, significant differences in the changes of FPG (fasting plasma glucose), PPG (postprandial plasma glucose), HbA1c (glycosylated hemoglobin), HOMA-IR (homeostasis model assessment of insulin resistance), TC (total cholesterol), TG (total triglycerides), and LDL-c (low-density lipoprotein cholesterol) were observed among the four groups. Compared to the healthy diet group, the 50 g-oats group had a bigger reduction in PPG (mean difference (MD): −1.04 mmol/L; 95% CI: −2.03, −0.05) and TC (MD: −0.24 mmol/L; 95% CI: −0.47, −0.01); the 100 g-oats group had a bigger reduction in PPG (MD: −1.48 mmol/L; 95% CI: −2.57, −0.39), HOMA-IR (MD: −1.77 mU·mol/L(2); 95% CI: −3.49, −0.05), TC (MD: −0.33 mmol/L; 95% CI: −0.56, −0.10) and LDL-c (MD: −0.22 mmol/L; 95% CI: −0.41, −0.03). In the 1-year follow-up, greater effects in reducing weight (MD: −0.89 kg; 95% CI: −1.56, −0.22), HbA1c (MD: −0.64%; 95% CI: −1.19, −0.09) and TG (MD: −0.70 mmol/L; 95% CI: −1.11, −0.29) were observed in the 100 g-oats group. In conclusion, short- and long-term oat intake had significant effects on controlling hyperglycemia, lowering blood lipid and reducing weight. Our study provided some supportive evidence for recommending oat as a good whole grain selection for overweight diabetics. MDPI 2016-09-07 /pmc/articles/PMC5037534/ /pubmed/27618090 http://dx.doi.org/10.3390/nu8090549 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Li, Xue
Cai, Xiaxia
Ma, Xiaotao
Jing, Lulu
Gu, Jiaojiao
Bao, Lei
Li, Jun
Xu, Meihong
Zhang, Zhaofeng
Li, Yong
Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial
title Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial
title_full Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial
title_fullStr Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial
title_full_unstemmed Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial
title_short Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial
title_sort short- and long-term effects of wholegrain oat intake on weight management and glucolipid metabolism in overweight type-2 diabetics: a randomized control trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037534/
https://www.ncbi.nlm.nih.gov/pubmed/27618090
http://dx.doi.org/10.3390/nu8090549
work_keys_str_mv AT lixue shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial
AT caixiaxia shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial
AT maxiaotao shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial
AT jinglulu shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial
AT gujiaojiao shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial
AT baolei shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial
AT lijun shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial
AT xumeihong shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial
AT zhangzhaofeng shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial
AT liyong shortandlongtermeffectsofwholegrainoatintakeonweightmanagementandglucolipidmetabolisminoverweighttype2diabeticsarandomizedcontroltrial